J. Garmendia

New 1,2,3‐Triazole Hybrids as Anticancer Agents: Design, Synthesis, Characterization, and In Silico Studies

Two series of 1,2,3‐triazole‐based molecules were synthesized. Their physical properties were documented, and cytotoxicity was evaluated against normal lymphocytes, leukemic, adherent, and nontumor cell lines. Compounds 11, 15, and 16 were inactive, while compound 17 affected both normal and cancer cells. Compounds 18...